Author: Spur Therapeutics

Posted Date:

February 4, 2026

Spur Therapeutics Presents New Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at 22nd Annual WORLDSymposium™

Spur Therapeutics

February 4, 2026